Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited released its Monthly Return for the period ended 31 May 2026, confirming that no changes occurred in either authorised or issued share capital during the month.

Authorised / Registered Share Capital • H shares: 219.90 million shares at RMB 1 par value. • A shares: 1,405.89 million shares at RMB 1 par value. Total authorised capital remained at 1,625.79 million shares, unchanged from April 2026.

Issued Share Capital and Treasury Position • H shares listed in Hong Kong (stock code 00874): 219.90 million issued shares; zero treasury shares. • A shares listed on the Shanghai Stock Exchange: 1,405.89 million issued shares; zero treasury shares. No share issuances, cancellations, conversions or repurchases were recorded, leaving total issued shares at 1,625.79 million.

Public Float The company confirmed compliance with Main Board Rule 13.32D(1), maintaining a public float above the 5% threshold required for PRC issuers with other listed shares.

Corporate Actions The filing states that during May 2026: • No share options, warrants, convertibles or other equity-linked instruments were outstanding or exercised. • No agreements or arrangements existed to issue additional shares. • No treasury share movements occurred.

Regulatory Confirmation The company secretary affirmed that all listing rule, legal and regulatory obligations were met, and no new securities requiring separate disclosure were issued.

The unchanged capital structure and adherence to float requirements highlight operational and regulatory stability for the month under review.